Molecular Biology in Clinical Oncology Workshop


Workshop Content
This is an intensive workshop providing a substantive overview of key areas in molecular biology, translational cancer research, current lab techniques, career development, and the best practices of grant writing for the aspiring physician-scientist.

Lectures: Our faculty experts will give overview lectures on key areas of translational cancer research, using examples of their research to demonstrate the process of developing experiments to interrogate hypothesis-driven scientific questions. Lecture faculty will facilitate stimulating discussion and will integrate career development advice through personal examples from their career paths.

Laboratories: Our laboratory faculty will run five hands-on laboratory sessions, demonstrating and discussing current lab techniques. These labs are conducted in small groups to maximize the learning experience and faculty interaction and will include topics such as gene expression analysis, proteomics, next-generation sequencing, bioinformatics, data analysis, CRISPR/gene editing, troubleshooting, and more.

Career Development and Mentoring: Participants will also benefit from sessions on career development, several opportunities to meet one-on-one with faculty members during scheduled “office hours”, and informal networking at meals.

Guidance in Grant Writing: The Workshop begins with a comprehensive lecture on the best practices of grant writing.  Over the week, participants will develop the specific aims of an imminent grant, career development award, or future proposed research project (submitted one week prior to the workshop).  Small groups of three or four participants and one or two faculty mentors will examine the hypothesis and aims and refine their work over the week using the best practices presented.

Faculty – Lecturers (as of 5/22/19)

  • Charles D. Drake, Columbia University Medical Center, New York, New York
  • Levi A. Garraway, Eli Lilly and Company, Indianapolis, Indiana
  • Mark W. Geraci, Indiana University, Indianapolis, Indiana
  • William C. Hahn, Dana-Farber Cancer Institute, Boston, Massachusetts
  • Carl H. June, Abramson Cancer Center at the University of Pennsylvania, Philadelphia, Pennsylvania
  • William G. Kaelin, Jr., Dana-Farber Cancer Institute, Boston, Massachusetts
  • David G. Kirsch, Duke University Medical Center, Durham, North Carolina
  • Ross L. Levine, Memorial Sloan Kettering Cancer Center, New York, New York
  • Christine M. Lovly, Vanderbilt University Medical Center, Nashville, Tennessee
  • Elizabeth A. Maher, UT Southwestern Medical Center, Dallas, Texas
  • Amanda J. Redig, Takeda Oncology, Cambridge, Massachusetts
  • David B. Solit, Memorial Sloan Kettering Cancer Center, New York, New York
  • Jean Y. Tang, Stanford University School of Medicine, Redwood City, California
  • Barry S. Taylor, Memorial Sloan Kettering Cancer Center, New York, New York

The program for the 2019 Workshop is currently under development.

For an example of the program and topics covered during the workshop, please see the sample program from the 2018 Molecular Biology in Clinical Oncology Workshop.